Literature DB >> 30472582

Simultaneous analysis by LC-MS/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue.

Merja R Häkkinen1, Teemu Murtola2, Raimo Voutilainen3, Matti Poutanen4, Tero Linnanen5, Johanna Koskivuori6, Timo Lakka7, Jarmo Jääskeläinen3, Seppo Auriola6.   

Abstract

This study describes a validated LC-MS/MS method for assaying 23 steroids within a single run from 150 μl of human plasma, serum or prostatic tissue homogenate. Isotope-labeled steroids were used as internal standards. Samples were extracted with toluene, and ketosteroids were derivatized with hydroxylamine prior to LC-MS/MS analysis. The steroids were separated on a C18 column and methanol was used as an organic solvent with the addition of 0.2 mM ammonium fluoride to improve underivatized estradiol (E2) ionization. Certified reference serums as well as plasma samples, and homogenates of prostate tissue were utilized in the method validation. The specificity of the method was inspected with a total of 27 steroids. The validation proved that the method was suitable for the quantitative analysis of a wide panel of androgens (testosterone, T (3.3 pM-13 nM); androstenedione, A4 (3.3 pM-13 nM); 5α-androstanedione, DHA4 (13 pM-13 nM); dehydroepiandrosterone, DHEA (67 pM-133 nM); dihydrotestosterone, DHT (33 pM-33 nM); 11-ketodihydrotestosterone, 11KDHT (13 pM-13nM); 11-ketotestosterone, 11KT (33 pM-6.7 nM); 11β-hydroxyandrostenedione, 11bOHA4 (33 pM-13 nM); 11β-hydroxytestosterone, 11OHT (13 pM-33 nM)), as well as estrogens (estrone, E1 (3.3 pM-13 nM)), progestagens (17α-hydroxypregnenolone, 17OHP5 (32 pM-127 nM); 17α-hydroxyprogesterone, 17OHP4 (67 pM-133 nM); progesterone, P4 (3.3 pM-13 nM); pregnenolone, P5 (6.6 pM-13 nM)), and glucocorticoids (cortisol, F (33 pM-134 nM); cortisone E (66 pM-131 nM); corticosterone, B (33 pM-67 nM); 11-deoxycortisol, S (33 pM-66 nM); 21-hydroxyprogesterone, 21OHP4 (32 pM-13 nM)). Furthermore, E2 (335 pM-134 nM) and 11α-hydroxyandrostenedione, 11aOHA4 (33 pM-33 nM) could be analyzed if the concentration in the sample was high enough. In addition, aldosterone, A (128 pM-64 nM) and 11-ketoandrostenedione, 11KA4 (33 pM-13 nM) could be analyzed semiquantitatively. The limits of quantification for all compounds ranged from 0.9 to 91 pg/ml, and from 0.009 to 0.9 pg/mg tissue. Compared to our previous method, this new method also permits the analysis of the more challenging steroids, like DHT, DHEA and P5, and a panel of 11-ketosteroids.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgens; LC–MS; Prostate; Serum; Steroids; Tissue

Mesh:

Substances:

Year:  2018        PMID: 30472582     DOI: 10.1016/j.jpba.2018.11.035

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

Review 1.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

2.  Quantitation of estradiol by competitive light-initiated chemiluminescent assay using estriol as competitive antigen.

Authors:  Jiuzhi Li; Liuxu Li; Ying Bian; Yang Yu; Zhonghua Qiang; Yuexiang Zhang; Huiqiang Li
Journal:  J Clin Lab Anal       Date:  2019-08-24       Impact factor: 2.352

3.  Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS.

Authors:  Hanne Frederiksen; Trine Holm Johannsen; Stine Ehlern Andersen; Jakob Albrethsen; Selma Kløve Landersoe; Jørgen Holm Petersen; Anders Nyboe Andersen; Esben Thyssen Vestergaard; Mia Elbek Schorring; Allan Linneberg; Katharina M Main; Anna-Maria Andersson; Anders Juul
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

Review 4.  Determination of Intraprostatic and Intratesticular Androgens.

Authors:  Markéta Šimková; Jiří Heráček; Pavel Drašar; Richard Hampl
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

5.  Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial.

Authors:  Paavo V H Raittinen; Heimo Syvälä; Teuvo L J Tammela; Merja R Häkkinen; Pauliina Ilmonen; Seppo Auriola; Teemu J Murtola
Journal:  EBioMedicine       Date:  2021-06-16       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.